"10.1371_journal.pgen.1001369","plos genetics","2011-04-21T00:00:00Z","Reo Maruyama; Sibgat Choudhury; Adam Kowalczyk; Marina Bessarabova; Bryan Beresford-Smith; Thomas Conway; Antony Kaspi; Zhenhua Wu; Tatiana Nikolskaya; Vanessa F Merino; Pang-Kuo Lo; X Shirley Liu; Yuri Nikolsky; Saraswati Sukumar; Izhak Haviv; Kornelia Polyak","Departments of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America; Department of Medicine, Brigham and Womens Hospital, Boston, Massachusetts, United States of America; Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America; NICTA Victoria Research Laboratory, The University of Melbourne, Melbourne, Victoria, Australia; Department of Electrical and Electronic Engineering, The University of Melbourne, Melbourne, Victoria, Australia; Thomson Reuters, Healthcare and Science, Encinitas, California, United States of America; Department of Computer Science and Software Engineering, The University of Melbourne, Melbourne, Victoria, Australia; Bioinformatics and System Integration, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America; Harvard School of Public Health, Boston, Massachusetts, United States of America; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Department of Biochemistry, The University of Melbourne, Melbourne, Victoria, Australia; Metastasis Research Lab, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Harvard Stem Cell Institute, Cambridge, Massachusetts, United States of America","Conceived and designed the experiments: RM SC KP. Performed the experiments: RM SC. Analyzed the data: RM SC AK MB BBS TC AK ZW XSL YN IH KP. Contributed reagents/materials/analysis tools: AK MB BBS TC AK ZW TN VFM PKL XSL YN SS IH. Wrote the paper: RM SC AK MB BBS TC AK ZW XSL YN IH KP.","KP receives research support from Novartis Oncology and is a consultant to Novartis Oncology. KP also serves on the Scientific Advisory Board of Metamark Genetics, Inc. and Theracrine, Inc. and holds AVEO Pharmaceuticals, Inc. stocks. TN and YN are founders and employees of GeneGo Inc.","2011","04","Reo Maruyama","RM",16,TRUE,3,2,11,11,TRUE,TRUE,FALSE,0,NA,FALSE
